Annual D&A
$640.60 K
-$122.40 K-16.04%
31 December 2023
Summary:
Corbus Pharmaceuticals Holdings annual depreciation & amortization is currently $640.60 thousand, with the most recent change of -$122.40 thousand (-16.04%) on 31 December 2023. During the last 3 years, it has fallen by -$1.05 million (-62.19%). CRBP annual D&A is now -62.19% below its all-time high of $1.69 million, reached on 31 December 2020.CRBP Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$152.00 K
+$1700.00+1.13%
30 September 2024
Summary:
Corbus Pharmaceuticals Holdings quarterly depreciation & amortization is currently $152.00 thousand, with the most recent change of +$1700.00 (+1.13%) on 30 September 2024. Over the past year, it has dropped by -$1000.00 (-0.65%). CRBP quarterly D&A is now -68.71% below its all-time high of $485.80 thousand, reached on 31 December 2021.CRBP Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$601.60 K
-$1000.00-0.17%
30 September 2024
Summary:
Corbus Pharmaceuticals Holdings TTM depreciation & amortization is currently $601.60 thousand, with the most recent change of -$1000.00 (-0.17%) on 30 September 2024. Over the past year, it has dropped by -$75.80 thousand (-11.19%). CRBP TTM D&A is now -64.49% below its all-time high of $1.69 million, reached on 31 December 2020.CRBP TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRBP Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -16.0% | -0.7% | -11.2% |
3 y3 years | -62.2% | -50.6% | -62.0% |
5 y5 years | +29.7% | -46.4% | -38.6% |
CRBP Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -62.2% | at low | -68.7% | +3.0% | -63.3% | at low |
5 y | 5 years | -62.2% | +29.7% | -68.7% | +3.0% | -64.5% | at low |
alltime | all time | -62.2% | -68.7% | +172.6% | -64.5% |
Corbus Pharmaceuticals Holdings Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $152.00 K(+1.1%) | $601.60 K(-0.2%) |
June 2024 | - | $150.30 K(-0.9%) | $602.60 K(-1.3%) |
Mar 2024 | - | $151.70 K(+2.8%) | $610.40 K(-4.7%) |
Dec 2023 | $640.60 K(-16.0%) | $147.60 K(-3.5%) | $640.60 K(-5.4%) |
Sept 2023 | - | $153.00 K(-3.2%) | $677.40 K(-5.3%) |
June 2023 | - | $158.10 K(-13.1%) | $715.20 K(-4.5%) |
Mar 2023 | - | $181.90 K(-1.4%) | $749.20 K(-1.8%) |
Dec 2022 | $763.00 K(-53.5%) | $184.40 K(-3.4%) | $763.00 K(-28.3%) |
Sept 2022 | - | $190.80 K(-0.7%) | $1.06 M(-9.9%) |
June 2022 | - | $192.10 K(-1.8%) | $1.18 M(-16.2%) |
Mar 2022 | - | $195.70 K(-59.7%) | $1.41 M(-14.0%) |
Dec 2021 | $1.64 M(-3.3%) | $485.80 K(+57.7%) | $1.64 M(+3.5%) |
Sept 2021 | - | $308.00 K(-26.8%) | $1.58 M(-2.3%) |
June 2021 | - | $420.90 K(-0.8%) | $1.62 M(-2.4%) |
Mar 2021 | - | $424.50 K(-1.2%) | $1.66 M(-2.0%) |
Dec 2020 | $1.69 M(+37.8%) | $429.80 K(+24.4%) | $1.69 M(+1.5%) |
Sept 2020 | - | $345.50 K(-25.1%) | $1.67 M(+3.9%) |
June 2020 | - | $461.00 K(+0.7%) | $1.61 M(+11.2%) |
Mar 2020 | - | $458.00 K(+13.1%) | $1.45 M(+17.6%) |
Dec 2019 | $1.23 M | $405.10 K(+42.9%) | $1.23 M(+25.5%) |
Sept 2019 | - | $283.50 K(-5.3%) | $980.10 K(+18.2%) |
June 2019 | - | $299.50 K(+23.9%) | $828.90 K(+159.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2019 | - | $241.80 K(+55.7%) | $320.00 K(-35.2%) |
Dec 2018 | $493.90 K(+93.2%) | $155.30 K(+17.4%) | $494.00 K(+22.5%) |
Sept 2018 | - | $132.30 K(-163.2%) | $403.30 K(+1.4%) |
June 2018 | - | -$209.40 K(-150.4%) | $397.60 K(-37.9%) |
Mar 2018 | - | $415.80 K(+543.7%) | $640.00 K(+150.3%) |
Dec 2017 | $255.70 K(+191.6%) | $64.60 K(-49.0%) | $255.70 K(+15.6%) |
Sept 2017 | - | $126.60 K(+283.6%) | $221.10 K(+92.3%) |
June 2017 | - | $33.00 K(+4.8%) | $115.00 K(+12.9%) |
Mar 2017 | - | $31.50 K(+5.0%) | $101.90 K(+16.2%) |
Dec 2016 | $87.70 K(+99.8%) | $30.00 K(+46.3%) | $87.70 K(+16.3%) |
Sept 2016 | - | $20.50 K(+3.0%) | $75.40 K(+8.3%) |
June 2016 | - | $19.90 K(+15.0%) | $69.60 K(+24.5%) |
Mar 2016 | - | $17.30 K(-2.3%) | $55.90 K(+27.0%) |
Dec 2015 | $43.90 K(+322.1%) | $17.70 K(+20.4%) | $44.00 K(+38.8%) |
Sept 2015 | - | $14.70 K(+137.1%) | $31.70 K(+44.7%) |
June 2015 | - | $6200.00(+14.8%) | $21.90 K(+37.7%) |
Mar 2015 | - | $5400.00(0.0%) | $15.90 K(+51.4%) |
Dec 2014 | $10.40 K(>+9900.0%) | $5400.00(+10.2%) | $10.50 K(+105.9%) |
Sept 2014 | - | $4900.00(+2350.0%) | $5100.00(+2450.0%) |
June 2014 | - | $200.00(>+9900.0%) | $200.00(>+9900.0%) |
Mar 2014 | - | $0.00 | $0.00 |
Dec 2013 | $0.00 | - | - |
FAQ
- What is Corbus Pharmaceuticals Holdings annual depreciation & amortization?
- What is the all time high annual D&A for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings annual D&A year-on-year change?
- What is Corbus Pharmaceuticals Holdings quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings quarterly D&A year-on-year change?
- What is Corbus Pharmaceuticals Holdings TTM depreciation & amortization?
- What is the all time high TTM D&A for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings TTM D&A year-on-year change?
What is Corbus Pharmaceuticals Holdings annual depreciation & amortization?
The current annual D&A of CRBP is $640.60 K
What is the all time high annual D&A for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high annual depreciation & amortization is $1.69 M
What is Corbus Pharmaceuticals Holdings annual D&A year-on-year change?
Over the past year, CRBP annual depreciation & amortization has changed by -$122.40 K (-16.04%)
What is Corbus Pharmaceuticals Holdings quarterly depreciation & amortization?
The current quarterly D&A of CRBP is $152.00 K
What is the all time high quarterly D&A for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high quarterly depreciation & amortization is $485.80 K
What is Corbus Pharmaceuticals Holdings quarterly D&A year-on-year change?
Over the past year, CRBP quarterly depreciation & amortization has changed by -$1000.00 (-0.65%)
What is Corbus Pharmaceuticals Holdings TTM depreciation & amortization?
The current TTM D&A of CRBP is $601.60 K
What is the all time high TTM D&A for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high TTM depreciation & amortization is $1.69 M
What is Corbus Pharmaceuticals Holdings TTM D&A year-on-year change?
Over the past year, CRBP TTM depreciation & amortization has changed by -$75.80 K (-11.19%)